Vitamins, Beauty, and Longevity Unite in a Single Ecosystem at Vitafoods Europe 2026
At the Barcelona expo, the main trend was 'nutricosmetics' (beauty-from-within), where collagen, personalized nutrition, and gut health are linked to skin health and active longevity.
Nutricosmetics moves from pill bottles to everyday drinks: what Vitafoods Europe 2026 revealed about the future of the beauty market
The Essence: What's Really Happening
From May 5 to 7, 2026, Barcelona hosted Vitafoods Europe, the largest global platform for the nutraceutical industry. Over 1,600 exhibitors and about 30,000 visitors from 135 countries. Three days of a packed program. But the main takeaway from the expo is not in attendance numbers or specific launches—it's that the beauty, nutrition, and longevity industries have finally ceased to be separate verticals and merged into a single ecosystem, where consumers no longer distinguish between a 'skin supplement,' an 'energy drink,' and a 'healthy aging product.'
Business headlines are full of the word 'nutricosmetics.' But the real story is deeper. Vitafoods 2026 showed that the beauty-from-within market is not just booming—it's undergoing a structural transformation. Tablets and capsules are being replaced by drinks, shots, and functional foods that fit into daily routines. And collagen—still the king of this market—is evolving from a 'protein for wrinkles' into a multifunctional platform for joint, bone, muscle, and skin health simultaneously.
Eight billion three hundred million dollars—that's the estimated global nutricosmetics market in 2026. The forecast for 2034 is nearly sixteen billion. Almost doubling in eight years. And Vitafoods showed who exactly will be dividing this pie.
Timeline and Context
The story that culminated in the Barcelona expo has been unfolding over the past two years. In April 2026, Vitafoods organizers first announced a dedicated nutricosmetics session for the third day of the expo. This was not a spontaneous decision. In 2025, the ingestible beauty market had grown enough to warrant its own stage—not just a corner at a booth, but a full conference track.
A month before the expo, in early April, the information space began filling with press releases from participating companies. Prinova announced the Everyday Wellness line—drinks with collagen, prebiotics, and plant protein, positioned not as sports nutrition or supplements, but as 'everyday health solutions.' DolCas Biotech introduced a new format of marine collagen, Morikol—a soluble powder in sachets that dissolves in the mouth without water or aftertaste. GELITA announced its debut at Vitafoods as the official collagen sponsor and brought a new bioactive peptide, CURADERM, for skin barrier function.
Meanwhile, organizers announced the inclusion of a new category in the Innovation Awards—Nutricosmetic Ingredient. This is a signal often overlooked: the industry has recognized nutricosmetics not as a subcategory of 'beauty' or 'sports nutrition,' but as an independent direction with its own evaluation criteria.
The day before the expo opened, Food Ingredients First published a preview with five key trends. Beauty-from-within was the first item.
Finally, on May 5-7, the expo took place. Everest Group, a consulting firm that tracks trends for investors, released a detailed analysis of the three days—and this document became the unofficial manifesto of a new era of connected wellness.
Who Wins and Who Loses
Collagen manufacturers win. Collagen remains the dominant nutricosmetic ingredient, and Vitafoods 2026 showed its role is only expanding. GELITA positions its bioactive peptides not as an 'anti-wrinkle supplement,' but as a platform for health at all life stages: athletes over 40, menopausal women, recovery from injuries. DolCas promotes Morikol with clinical data: improved hydration and reduced wrinkles in six to twelve weeks at a dose of just 1-2 grams per day. This is radically lower than the typical recommendation of 2.5-10 grams for regular collagen—and it changes the product's economics. Lower dose means lower cost per serving, wider audience.
Companies betting on drinks rather than capsules win. Prinova showcased RTD concepts: Everyday Radiance drink with marine collagen and Aquamin bioactive minerals, Everyday Harmony with prebiotic fibers and ginger-lime, Everyday Protein based on clear pea protein. Formats—bottles and cans, not blister packs. Essential Protein Solutions presented a fruit cocktail prototype with fish collagen, containing nearly 10 grams of collagen per 100 grams of drink. TOSLA and Geltor collaborated on a vegan signaling collagen PrimaColl Type 21 in a liquid shot format with cherry and raspberry flavor. The logic is simple: consumers are more likely to drink a beverage than swallow a capsule. It's a ritual, not a medical procedure.
Brands with a scientific foundation win. Vitafoods 2026 showed that evidence-based positioning is becoming a market entry pass. DolCas published placebo-controlled studies. GELITA—data on Verisol, Fortigel, Fortibone. TOSLA and Geltor—clinical trials with 80-92% of participants reporting improved skin firmness and elasticity. At the conference, it was increasingly heard: credibility is a competitive advantage. Consumers are tired of influencer claims and seek products with proof.
Traditional capsule supplement manufacturers lose. If the trend toward drinks and functional foods continues, capsules will lose share not because they work worse, but because they integrate less into daily life. Vitafoods confirmed this definitively: the boundary between supplement and food is blurring.
Brands that position collagen only as a beauty ingredient lose. New launches from GELITA and DolCas show that the same peptide can be sold in anti-aging creams, sports supplements, and joint health products. This expands the addressable market manifold—but requires a completely different marketing architecture.
Companies ignoring women's health as a separate platform lose. Day 2 of the expo was dedicated to women's health—and this is not about 'pink marketing,' but about segmentation by life stages: cycle, perimenopause, postmenopause, bone health. GELITA explicitly states: after menopause, the risk of osteoporosis increases, and collagen peptides for bones (FORTIBONE) and joints (FORTIGEL) are women's health, not generic joint health. AB-Biotics brought an updated Gyntima portfolio for menopause, fertility, and iron absorption. Those who still produce 'collagen for everyone' are losing the most solvent audience.
What the Media Isn't Saying
Insight #1: Nutricosmetics is becoming a Trojan horse for GLP-1 companion nutrition.
The most important but least covered trend in mainstream media at Vitafoods is the link between beauty-from-within and GLP-1 companion nutrition. GLP-1 agonists (Ozempic, Wegovy, and analogs) are rapidly changing the nutrition landscape: people eat less, feel full faster, lose weight, but along with fat, muscle mass is lost, and skin faces the consequences of rapid weight loss. Collagen and nutricosmetic manufacturers have found the perfect entry point: collagen supports skin during weight loss, protein preserves muscle, prebiotics ease digestion amid altered appetite. This opens a market no one thought about two years ago: people on medication-induced weight loss become the target audience for beauty-from-within.
Insight #2: Vegan signaling collagen is not an ethical niche, but the next technological frontier.
The TOSLA and Geltor collaboration at Vitafoods presented PrimaColl Type 21—a biodesigned vegan signaling collagen produced by precision fermentation. This is not just a 'vegan alternative.' It's a fundamentally different product: it doesn't serve as a building block for collagen, but sends a signal to fibroblasts to produce their own collagen. The difference is like supplying bricks to a construction site versus hiring a foreman who organizes the building. Clinical data—80-92% of participants with improved firmness and elasticity—makes this product a competitor not to vegan niche brands, but to traditional animal collagen. When biotech collagen matches the price of animal collagen—and that's a matter of a few years—the market will flip.
Insight #3: The collagen market is moving from 'more grams per dollar' to 'fewer grams, but smarter.'
DolCas with Morikol claimed an effective dose of 1-2 grams per day—versus 2.5-10 grams for regular collagen. This is not just a marketing advantage. It's a paradigm shift. For years, consumers heard: 'you need a lot of collagen, at least 10 grams a day.' That meant large portions, inconvenience, and high daily dose cost. Now products appear where 1 gram works—because it's not just amino acids, but specific tripeptide sequences GPH that act as signaling molecules. Consumers pay not for grams of protein, but for bioactive signaling. This moves collagen from a commodity product to a specialized ingredient with a protected price.
Forecast: Next 30 Days and 90 Days
30 days (by June 13, 2026):
The expo is over, but its consequences are just beginning to unfold. In the next month, we will see the first wave of commercial launches announced at Vitafoods. Prinova will start pilot deliveries of Everyday Wellness concepts to retailers in Europe and North America. TOSLA and Geltor will launch a limited batch of Signaling Collagen Shot for pre-order—this will test consumer interest before full-scale rollout.
Data from the expo will begin circulating among investors. Everest Group has already released its report—it will land on the desks of venture capital funds specializing in wellness and longevity. This will trigger at least 2-3 pre-seed and seed rounds in startups at the intersection of beauty-from-within and GLP-1 companion nutrition within the next 30 days.
Meanwhile, we will see Amazon's reaction: the platform closely monitors trends from Vitafoods to update its Beauty & Personal Care category. Expect new nutricosmetic brands to appear in the Premium Beauty section with Prime delivery.
90 days (by mid-August 2026):
By the end of summer, structural shifts will become apparent. First, one of the major players—Nestlé Health Science, Unilever Prestige, or L'Oréal—will announce an acquisition or strategic partnership with a company in the biofermented collagen segment. Geltor's technology (precision fermentation) is too expensive for independent scaling, but too promising to ignore. The deal size could range from $200 million to $500 million.
Second, the nutricosmetic drink category will begin to displace capsules on retailer shelves. The ready-to-drink formats shown at Vitafoods will go from 'innovative concepts' to 'must-have assortment' in chains like Whole Foods, Sephora, and Ulta. The share of drinks in the beauty-from-within segment will grow from the current 15-20% to 30% by year-end.
Third, GLP-1 companion nutrition will become the hottest phrase in the beauty and nutraceutical industry. Companies that showcased products for Ozempic users at Vitafoods will secure contracts with telehealth platforms prescribing these drugs. A new distribution channel will emerge: a collagen drink prescribed alongside a semaglutide prescription—as supportive therapy for skin and muscles.
Finally, we will see an update to the regulatory landscape. Geltor's PrimaColl has FDA GRAS status but is not authorized in the European Union and the UK. This will create tension between the American and European markets: while European regulators review applications, American brands will gain a 12-18 month head start. By August, this disparity will become noticeable—and will trigger lobbying from European companies to accelerate the Novel Food approval process for fermented collagens.
Conclusion. Vitafoods Europe 2026 will go down in history not as 'the expo where a lot of collagen was shown.' It will go down in history as the moment when the nutricosmetics industry ceased to be 'beauty supplements' and became a full-fledged ecosystem at the intersection of nutrition, longevity, women's health, and pharmaceutical support. Collagen is evolving from a mono-product into a platform. Drinks are displacing capsules. GLP-1 opens a new audience. Biotechnologies create vegan collagen that works not as a building material, but as a signaling molecule. Boundaries are crumbling, and those who continue to think in categories of 'this is a supplement,' 'this is sports nutrition,' 'this is cosmetics' will lose to those who understood: consumers want connected wellness, not isolated jars on a shelf.
— Editorial Team
